NASDAQ: OXBR
Oxbridge Re Holdings Ltd Stock Forecast, Predictions & Price Target

Analyst price target for OXBR

Based on 1 analyst offering 12 month price targets for Oxbridge Re Holdings Ltd

Min Forecast
$5.00+216.46%
Avg Forecast
$5.00+216.46%
Max Forecast
$5.00+216.46%

Should I buy or sell OXBR stock?

Based on 1 analyst offering ratings for Oxbridge Re Holdings Ltd.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their OXBR stock forecasts and price targets.

OXBR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-30

1 of 1

Forecast return on equity

Is OXBR forecast to generate an efficient return?

Company
15.83%
Industry
16.61%
Market
268.35%
OXBR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is OXBR forecast to generate an efficient return on assets?

Company
9.22%
Industry
3.13%
OXBR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

OXBR earnings per share forecast

What is OXBR's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.01
Avg 2 year Forecast
-$0.02
Avg 3 year Forecast
$0.11

OXBR revenue forecast

What is OXBR's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$3.3M-23.82%
Avg 2 year Forecast
$4.6M+8.28%
Avg 3 year Forecast
$8.6M+100.56%
OXBR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

OXBR revenue growth forecast

How is OXBR forecast to perform vs Insurance - Reinsurance companies and vs the US market?

Company
13.29%
Industry
1.54%
Market
58.52%
OXBR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
OXBR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

OXBR vs Reinsurance Insurance Stocks

TickerPricePrice TargetUp/downsideConsensus
OXBR$1.58$5.00+216.46%Strong Buy
GLRE$12.13N/AN/A
SPNT$18.19$27.50+51.18%Strong Buy
HG$23.75$27.33+15.09%Buy
AHL$36.76$39.44+7.29%Buy

Oxbridge Re Holdings Stock Forecast FAQ

Is Oxbridge Re Holdings Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: OXBR) stock is to Strong Buy OXBR stock.

Out of 1 analyst, 1 (100%) are recommending OXBR as a Strong Buy, 0 (0%) are recommending OXBR as a Buy, 0 (0%) are recommending OXBR as a Hold, 0 (0%) are recommending OXBR as a Sell, and 0 (0%) are recommending OXBR as a Strong Sell.

If you're new to stock investing, here's how to buy Oxbridge Re Holdings stock.

What is OXBR's earnings growth forecast for 2025-2027?

(NASDAQ: OXBR) Oxbridge Re Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Insurance - Reinsurance industry's average forecast earnings growth rate of 42.72%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 102.26%.

Oxbridge Re Holdings's earnings in 2025 is -$3,012,000.On average, 3 Wall Street analysts forecast OXBR's earnings for 2025 to be $76,866, with the lowest OXBR earnings forecast at $73,852, and the highest OXBR earnings forecast at $79,127. On average, 3 Wall Street analysts forecast OXBR's earnings for 2026 to be -$153,733, with the lowest OXBR earnings forecast at -$147,704, and the highest OXBR earnings forecast at -$158,254.

In 2027, OXBR is forecast to generate $845,530 in earnings, with the lowest earnings forecast at $812,372 and the highest earnings forecast at $870,399.

What is OXBR's revenue growth forecast for 2025-2027?

(NASDAQ: OXBR) Oxbridge Re Holdings's forecast annual revenue growth rate of 13.29% is forecast to beat the US Insurance - Reinsurance industry's average forecast revenue growth rate of 1.54%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.52%.

Oxbridge Re Holdings's revenue in 2025 is $4,286,000.On average, 3 Wall Street analysts forecast OXBR's revenue for 2025 to be $24,604,785, with the lowest OXBR revenue forecast at $23,640,187, and the highest OXBR revenue forecast at $25,328,234. On average, 3 Wall Street analysts forecast OXBR's revenue for 2026 to be $34,974,214, with the lowest OXBR revenue forecast at $33,602,676, and the highest OXBR revenue forecast at $36,006,635.

In 2027, OXBR is forecast to generate $64,778,786 in revenue, with the lowest revenue forecast at $62,231,644 and the highest revenue forecast at $66,677,838.

What is OXBR's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: OXBR) forecast ROA is 9.22%, which is higher than the forecast US Insurance - Reinsurance industry average of 3.13%.

What is OXBR's Price Target?

According to 1 Wall Street analyst that have issued a 1 year OXBR price target, the average OXBR price target is $5.00, with the highest OXBR stock price forecast at $5.00 and the lowest OXBR stock price forecast at $5.00.

The Wall Street analyst predicted that Oxbridge Re Holdings's share price could reach $5.00 by Apr 30, 2026. The average Oxbridge Re Holdings stock price prediction forecasts a potential upside of 216.46% from the current OXBR share price of $1.58.

What is OXBR's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: OXBR) Oxbridge Re Holdings's current Earnings Per Share (EPS) is -$0.44. On average, analysts forecast that OXBR's EPS will be $0.01 for 2025, with the lowest EPS forecast at $0.01, and the highest EPS forecast at $0.01. On average, analysts forecast that OXBR's EPS will be -$0.02 for 2026, with the lowest EPS forecast at -$0.02, and the highest EPS forecast at -$0.02. In 2027, OXBR's EPS is forecast to hit $0.11 (min: $0.11, max: $0.12).

What is OXBR's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: OXBR) forecast ROE is 15.83%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.